HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lot A Devriese Selected Research

Epidermal Growth Factor (EGF)

8/2012Validation of a multiparameter flow cytometry method for the determination of phosphorylated extracellular-signal-regulated kinase and DNA in circulating tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lot A Devriese Research Topics

Disease

9Neoplasms (Cancer)
01/2022 - 08/2012
8Squamous Cell Carcinoma of Head and Neck
01/2022 - 01/2019
5Head and Neck Neoplasms (Head and Neck Cancer)
07/2022 - 01/2020
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2020
2Nausea
01/2022 - 01/2020
2Prostatic Neoplasms (Prostate Cancer)
12/2021 - 01/2021
2Circulating Neoplastic Cells
08/2012 - 12/2011
1Thrombocytopenia (Thrombopenia)
01/2022
1Neutropenia
01/2022
1Fatigue
01/2022
1Esophagitis
01/2022
1Leukopenia
01/2022
1Salivary Gland Neoplasms (Salivary Gland Cancer)
12/2021
1Disease Progression
12/2021
1multiple Basal cell carcinoma
01/2021
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021
1Basal Cell Carcinoma (Rodent Ulcer)
01/2021
1Infections
01/2021
1Basal Cell Nevus Syndrome (Gorlin Syndrome)
01/2021
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2020
1Merkel Cell Carcinoma
01/2020
1Exanthema (Rash)
01/2020
1Breast Neoplasms (Breast Cancer)
02/2013

Drug/Important Bio-Agent (IBA)

3Cisplatin (Platino)FDA LinkGeneric
07/2022 - 01/2022
3LigandsIBA
01/2022 - 01/2020
3Biomarkers (Surrogate Marker)IBA
12/2021 - 12/2011
2NivolumabIBA
01/2021 - 01/2020
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2022
1PlatinumIBA
01/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022
1Cytostatic AgentsIBA
01/2022
1Death Domain ReceptorsIBA
01/2022
1Alanine Transaminase (SGPT)IBA
01/2022
1AntigensIBA
12/2021
1Proteins (Proteins, Gene)FDA Link
12/2021
1177Lu-PSMA-617IBA
12/2021
1Circulating Tumor DNAIBA
12/2021
1Cell-Free Nucleic AcidsIBA
12/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1CarcinogensIBA
01/2021
1HhAntag691IBA
01/2021
1Ritonavir (Norvir)FDA Link
01/2021
1Docetaxel (Taxotere)FDA Link
01/2021
1dacomitinibIBA
01/2020
1mirdametinibIBA
01/2020
1Pharmaceutical PreparationsIBA
01/2019
1eribulinFDA Link
02/2013
1taxaneIBA
02/2013
1Epidermal Growth Factor (EGF)IBA
08/2012
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
08/2012
1DNA (Deoxyribonucleic Acid)IBA
08/2012

Therapy/Procedure

4Chemoradiotherapy
01/2022 - 01/2020
4Therapeutics
12/2021 - 01/2017
2Enteral Nutrition (Feeding, Tube)
01/2022 - 01/2020
2Drug Therapy (Chemotherapy)
01/2022 - 01/2022
1Radiotherapy
12/2021
1Castration
01/2021
1Immunotherapy
01/2021
1Neoadjuvant Therapy
01/2021
1Gastrostomy
01/2020